The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.
about
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and woundsHuman polyserase-2, a novel enzyme with three tandem serine protease domains in a single polypeptide chainIdentification and characterization of human and mouse ovastacin: a novel metalloproteinase similar to hatching enzymes from arthropods, birds, amphibians, and fishProtein-bound polysaccharide from Phellinus linteus inhibits tumor growth, invasion, and angiogenesis and alters Wnt/β-catenin in SW480 human colon cancer cellsVEGF-initiated angiogenesis and the uPA/uPAR systemSingle amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasionOrganization, evolution and functions of the human and mouse Ly6/uPAR family genesRoles of low-density lipoprotein receptor-related protein 1 in tumorsModulation of CD44 Activity by A6-PeptideCOX-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectorsPosttranscriptional regulation of cancer traits by HuRAssignment of the four disulfides in the N-terminal somatomedin B domain of native vitronectin isolated from human plasmaInflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort studyIsothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate CancerCellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.uPAR-induced cell adhesion and migration: vitronectin provides the keyComparative analysis of metastasis variants derived from human prostate carcinoma cells: roles in intravasation of VEGF-mediated angiogenesis and uPA-mediated invasionCoexpression of invasive markers (uPA, CD44) and multiple drug-resistance proteins (MDR1, MRP2) is correlated with epithelial ovarian cancer progression.The plasminogen system in microdissected colonic mucosa distant from an isolated adenoma.Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas.Discovery and validation of an INflammatory PROtein-driven GAstric cancer Signature (INPROGAS) using antibody microarray-based oncoproteomicsProteases Revisited: Roles and Therapeutic Implications in Fibrosis.Elastin peptides regulate HT-1080 fibrosarcoma cell migration and invasion through an Hsp90-dependent mechanismThe urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells.Urokinase-type plasminogen activator receptor signaling is critical in nasopharyngeal carcinoma cell growth and metastasis.uPAR and HER2 Genes Are Usually Co-Amplified in Individual Breast Cancer Cells from Blood and Tissues.Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence.Heat shock proteins HSP70 and MRJ cooperatively regulate cell adhesion and migration through urokinase receptor.MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes.ATF3 functions as a novel tumor suppressor with prognostic significance in esophageal squamous cell carcinoma.Involvement of the soluble urokinase receptor in chondrosarcoma cell mobilization.PAI-1 4G/5G polymorphism contributes to cancer susceptibility: evidence from meta-analysisA pan-cancer analysis of alternative splicing events reveals novel tumor-associated splice variants of matriptase.MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.Impaired MicroRNA Processing Facilitates Breast Cancer Cell Invasion by Upregulating Urokinase-Type Plasminogen Activator ExpressionOncogenic K-Ras and loss of Smad4 mediate invasion by activating an EGFR/NF-κB Axis that induces expression of MMP9 and uPA in human pancreas progenitor cells.Spatiotemporal expression of SERPINE2 in the human placenta and its role in extravillous trophoblast migration and invasionActivation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cellsComputational survey of peptides derived from disulphide-bonded protein loops that may serve as mediators of protein-protein interactionsCirculating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients
P2860
Q21146433-1AE1B011-5A43-43EF-ACDA-59342F7BD86EQ24313309-01FC1DD4-72C5-4F88-A51B-323AE9640771Q24337050-CB74E8BB-473F-40A0-AA06-7B3AE77C8E51Q24619400-0C058733-AF04-4DD4-8546-EE4E5665E474Q27025897-E5BBFC2C-72C3-4014-B6C9-AFAD1FFA7870Q27319474-0BF2C5B8-DCB6-4F61-BB4B-6F7D036E48A6Q28071700-032080EB-8763-428E-BB42-7E67CC4ECDF8Q28078531-6317A08C-183A-46D0-817B-DC348CA96BB2Q28085166-6860442E-4010-4AD2-B43F-AECA6312E27CQ28199336-825C4EC8-78D3-458C-BC20-94275D040740Q28248667-78E7448B-D264-424E-83AE-E75BD418009EQ28264463-FF719F2A-5E5A-49AB-8537-F211C7E90005Q28484274-3EC7F091-9D5B-4B45-BE5D-44ECF5F905BFQ28821362-597E36C1-FED9-49FA-A47D-73E0CA404BC3Q30439922-2BDE07CE-545B-4527-A11A-C4FB3099B3F2Q30444144-F9CCEF48-C4DB-4A2C-B808-EC76B1B4901EQ30490521-9A166E5B-E41E-4E87-9592-F50867ADE749Q33482138-97A6CA23-F25E-4275-90E8-288F3B6EE9A2Q33585332-C4E9A1FB-38E6-4127-82B7-BF8500FE9E5AQ33683537-B8BB9E11-41D0-44C0-A688-BF247BE987B5Q33688456-D2306146-95C2-46AD-9657-AF5FC8F7DEF4Q33795055-AF3A6F0B-5DFC-45F3-9544-9395C50D0230Q33877418-CCCB9A21-D3DE-4EA1-A2FE-4C43CD09D1EBQ33938369-7EDF88D2-D1A8-4BF8-8DC0-39FE8FBDE4D2Q33953134-1AABBC4E-DABC-4345-871A-A108196E954CQ34095775-1E7C142A-D34E-4E2F-B042-C61CB0C07F9BQ34100895-E4264356-39DE-4E64-8F84-3027C5FEC813Q34157183-07DDF290-AAEC-4A6C-BF4B-603492A0DEADQ34311680-5BAB2ACB-17FF-44F0-8253-4918A23BB0B5Q34483678-D9CD943E-7EE2-434D-B13E-4CC5A8B706DDQ34495535-E0071C69-45D7-456C-93EC-01D0DCFDE66CQ34599478-A4B61F16-4CF3-4D63-9748-92974E5385A2Q34655203-3BDA43C5-1593-4D39-B093-7D82FCA2299DQ34737810-8C5A1D1F-7BCB-4B88-86E2-9050CA0E37CAQ35034871-3B117F3C-D7F8-416B-8876-A479AC93C409Q35067751-33663952-D0B6-4A00-9801-3E403DC6AE6FQ35181669-7DE47DE3-B736-4C4F-B2DB-C36DF7F043C5Q35238060-7CDB605C-3509-4C37-ABC3-6A356D326BC0Q35260240-572C154C-CC0C-49DA-97F6-6193377EB3F5Q35567020-15B5FA1A-549D-43D6-9986-22EFE8FA9610
P2860
The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The urokinase plasminogen acti ...... ion for prognosis and therapy.
@ast
The urokinase plasminogen acti ...... ion for prognosis and therapy.
@en
type
label
The urokinase plasminogen acti ...... ion for prognosis and therapy.
@ast
The urokinase plasminogen acti ...... ion for prognosis and therapy.
@en
prefLabel
The urokinase plasminogen acti ...... ion for prognosis and therapy.
@ast
The urokinase plasminogen acti ...... ion for prognosis and therapy.
@en
P356
P1476
The urokinase plasminogen acti ...... tion for prognosis and therapy
@en
P2093
Francesco Blasi
P2888
P304
P356
10.1023/A:1023099415940
P577
2003-06-01T00:00:00Z
P6179
1011821743